BRD2 and neoplasm: To compare the proteomic profiles between the two NAT subtypes and healthy liver, 14 newly collected healthy liver tissues, and 23 NATs from each NAT subtype and their paired tumor tissues randomly selected from the 159-patient cohort in the previous study [3] were assessed using DIA-MS analysis (Fig. 4a and Table S5).